Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998
Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998
Rafractory Status Epilepticus:Response to Ketamine
Neurol 51:1765-1766, Sheth,R.D. & Gidal,B.E., 1998
Early Structural Changes in Acute MS Lesions Assessed by Serial magnetization Transfer Studies
Neurol 51:1150-1155, Dousset,V.,et al, 1998
Subdural Haemorrhages in Infants:Population Based Study
BMJ 317:1558-1561,1538, Jayawant,S.,et al, 1998
Six-Month Evaluation of Carbatrol (Extended-Release Carbamazepine) in Complex Partial Seizures
Neurol 519:1727-1729, Mirza,W.U.,et al, 1998
Neuropsychiatric Sequelae One Year after a Minor Head Injury
JNNP 65:899-902,809, Deb,S.,et al, 1998
Current Immunotherapy in Multiple Sclerosis
Immunology and Cell Biology 76:55-64, Bashir,K.&Whitaker,J.N., 1998
Women's Health Issues, Part 1
Med Clin North Am 82:77-101, Belilos,E. & Carsons,S., 1998
Flail Arm Syndrome: A Distinctive Variant of Amyotrophic Lateral Sclerosis
JNNP 65:950-951, Hu, M.T.M.,et al, 1998
Risk of Unprovoked Seizure After Acute Symptomatic Seizure: Effect of Status Epilepticus
Ann Neurol 44:908-912, Hesdorffer,D.C.,et al, 1998
Herpes Simplex Encephalitis (HSE) and the Immunocompromised: A Clinical and Autopsy Study of HSE in the Settings of Cancer and Human Immunodeficiency Virus-Type 1 Infection
Hum Pathol 29:215-222, Schiff,D. &Rosenblum,M.K., 1998
Herpes Simplex Virus Infections of the Central Nervous System in Human Immunodeficiency Virus-Infected Patients: Clinical Management by Polymerase Chain Reaction Assay of Cerebrospinal Fluid
CID 27:303-309, Cinque,P., et al, 1998
Magnetic Resonance Imaging Features of Solitary Inflammatory Brain Masses
J Neuroimag 8:8-14, Bakshi,R.,et al, 1998
Permanent Visual Loss and Cerebrovascular Accidents in Giant Cell Arteritis: Predictors and Response to Treatment
Arthritis Rheum 41:1497-1504, Gonzalez-Gay,M.,et al, 1998
Specific Changes in Human Brain After Hypoglycemic Injury
Stroke 28:584-587, Fujioka,M.,et al, 1997
Myocardial Ischemia with Normal Coronary Arteries Associated with Thoracic Myelitis
NEJM 337:1920, Lalouschek,W.,et al, 1997
Trigeminal Neuralgia in Patients with Multiple Sclerosis:Lesion Localization with magnetic Resonance Imaging
Neurol 49:1142-1144, Gass,A.,et al, 1997
The Quality-of-Life Effects of Interferon Beta-1b in MS
Arch Neurol 54:1475-1480, Schwartz,C.E.,et al, 1997
Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Chromosome 19 Single-Locus & Multilocus Haplotype Assoc with MS, Evid of New Suscept Locus in Caucasian & Chinese Pts
JAMA 278:1256-1262, 12821997., Barcellos,L.F.,et al, 1997
Strong Clustering and Stereotyped Nature of Notch3 Mutations, in CADASIL Patients
Lancet 350:1511-1515, 14901997., Joutel,A.,et al, 1997
Symptomatic Carotid Artery Occlusion, A Reappraisal of Hemodynamic Factors
Stroke 28:2084-2093, Klijn,C.J.M.,et al, 1997
Gabapentin Monotherapy:An 8-Day, Study in Hosp Pts with Refractory Complex Partial or Secondarily Gen Seizures
Neurol 49:739-745, Bergey,G.K.,et al, 1997
Multiple Sclerosis, Depression, and Suicide
BMJ 315:691-692, Feinstein,A., 1997
Tizanidine for Spasticity
The Medical Letter 39:62, , 1997
Multiple Sclerosis Lesion Detection in the Brain:A Comparison of FLAIR & Conventional T2-Weighted Dual Spin Echo
Neurol 49:364-370, Gawne-Cain,M.L.,et al, 1997
Ischemic Lesion Volumes in Acute Stroke by Diffusion-Weighted MRI Correlate with Clinical Outcome
Ann Neurol 42:164-170, Lovblad,K-O.,et al, 1997
Clinical Characteristics of Patients with Motor Disability Due to Conversion Disorder:A Prospective Study
JNNP 63:83-88, Binzer,M.,et al, 1997
Risk Factors for Status Epilepticus in Children with Symptomatic Epilepsy
Neurol 49:533-537, Novak,G.,et al, 1997
Clinicopath Conf
Dysembryoplastic Neuroepithelial Tumor, Case 14-1997, NEJM 336:1373-1379997., , 1997
Refractory Giant Cell Arteritis with Spinal Cord Infarction
Neurol 49:1720-1723, Galetta,S.L.,et al, 1997
Giant Cell Arteritis With Unusual Flow-Related Neuroophthalmologic Manifestations
Neurol 49:1463-1465, Galetta,S.L.,et al, 1997
Color Duplex Ultrasonography in the Diagnosis of Temporal Arteritis
NEJM 337:1336-1386, 13851997., Schmidt,W.A.,et al, 1997
Granulomatous Angiitis of the Nervous System
In Vasculitis & The Nervous System, Neurol Clin 15:821-83497., Younger,D.S.,et al, 1997
Diffusion-Weighted MRI in Transient Global Amnesia Precipitated by Cerebral Angiography
Stroke 28:2311-2314, Woolfenden,A.R.,et al, 1997
Alternating Amaurosis Fugax and Temporal Arteritis
Am J Ophthalmol 123:850-851, Finelli,P.F., 1997
Polymyalgia Rheumatica and Temporal Arteritis:Diagnosis and Management
BMJ 314:1329-1332, Swannell,A.J., 1997
Percutaneous Transluminal Angioplasty for Total Occlusion of Middle Cerebral Arteries
Neuroradiology 39:71-74, Mori,T.,et al, 1997
Treatment of Multiple Cerebral Emboli from an Ulcerated, Thrombogenic Ascending Aorta with Aortectomy and Graft Replacement
Neurol 49:621-622, Belden,J.R.,et al, 1997
Paramedian Pontine Infarction
Stroke 28:809-815, Kataoka,S.,et al, 1997
Cystlike White Matter Lesions in Tuberous Sclerosis
AJNR 18:1367-1373, VanTassel,P.,et al, 1997
Offspring Recurrence Rates and Clinical Characteristics of Conjugal Multiple Sclerosis
Lancet 349:1587-1590, Robertson,N.P.,et al, 1997
Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997
Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997
The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997